$DERM Income Statement | Understand Stock

$DERM

$4.96 -$0.01 (0.2%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue:
Product revenue, net
Other revenue
Total revenue
Operating expenses
Cost of goods sold - (excluding amortization of acquired intangible assets)
Amortization of acquired intangible assets
Research and development
Research and development - licenses acquired
Selling, general and administrative
Wire transfer fraud loss
Loss on impairment of intangible assets
Loss recovery
Total operating expenses

Loss from operations
Other expense (income)
Interest income
Interest expense
Gain on extinguishment of debt
Foreign exchange transaction losses
Change in fair value of derivative liability
Total other expense

Loss before income taxes
Income tax expense
Net loss
Net loss per common share:
Basic (In dollars per share)
Diluted (In dollars per share)
Weighted average number of common shares:
Basic (In shares)
Diluted (In shares)

Comments